Abstract
Microglial function declines during aging. The interaction of microglia with the gut microbiota has been well characterized during development and adulthood but not in aging. Here, we compared microglial transcriptomes from young-adult and aged mice housed under germ-free and specific pathogen-free conditions and found that the microbiota influenced aging associated-changes in microglial gene expression. The absence of gut microbiota diminished oxidative stress and ameliorated mitochondrial dysfunction in microglia from the brains of aged mice. Unbiased metabolomic analyses of serum and brain tissue revealed the accumulation of N6-carboxymethyllysine (CML) in the microglia of the aging brain. CML mediated a burst of reactive oxygen species and impeded mitochondrial activity and ATP reservoirs in microglia. We validated the age-dependent rise in CML levels in the sera and brains of humans. Finally, a microbiota-dependent increase in intestinal permeability in aged mice mediated the elevated levels of CML. This study adds insight into how specific features of microglia from aged mice are regulated by the gut microbiota.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data on TwinsUK twin participants are available to bona fide researchers under managed access due to governance and ethical constraints. Raw data should be requested (http://twinsuk.ac.uk/resources-for-researchers/access-our-data/) and requests are going to be reviewed by the TwinsUK Resource Executive Committee regularly. Microglia RNA-seq data are available at the Gene Expression Omnibus under accession no. GSE182719. The mouse genome version mm10 (University of California Santa Cruz) can be viewed at https://www.ncbi.nlm.nih.gov/assembly/GCF_000001635.20/. For microbiome profiling, the FASTA files of two runs with their corresponding mappings are available at https://doi.org/10.6084/m9.figshare.15179775.v1 (ref. 64). Other data that support the findings of this study are available from the corresponding author upon reasonable request. Source data are provided with this paper.
References
Prinz, M., Masuda, T., Wheeler, M. A. & Quintana, F. J. Microglia and central nervous system-associated macrophages—from origin to disease modulation. Annu. Rev. Immunol. 39, 251–277 (2021).
Salter, M. W. & Beggs, S. Sublime microglia: expanding roles for the guardians of the CNS. Cell 158, 15–24 (2014).
Streit, W. J., Sammons, N. W., Kuhns, A. J. & Sparks, D. L. Dystrophic microglia in the aging human brain. Glia 45, 208–212 (2004).
Johnson, K. V. & Foster, K. R. Why does the microbiome affect behaviour? Nat. Rev. Microbiol. 16, 647–655 (2018).
Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965–977 (2015).
Matcovitch-Natan, O. et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science 353, aad8670 (2016).
Thion, M. S. et al. Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell 172, 500–516.e516 (2018).
Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K. & Mazmanian, S. K. Microbiome–microglia connections via the gut–brain axis. J. Exp. Med. 216, 41–59 (2019).
Mossad, O. & Blank, T. Getting on in old age: how the gut microbiota interferes with brain innate immunity. Front. Cell. Neurosci. 15, 698126 (2021).
Lakshminarayanan, B., Stanton, C., O’Toole, P. W. & Ross, R. P. Compositional dynamics of the human intestinal microbiota with aging: implications for health. J. Nutr. Health Aging 18, 773–786 (2014).
O’Toole, P. W. & Jeffery, I. B. Gut microbiota and aging. Science 350, 1214–1215 (2015).
Langille, M. G. et al. Microbial shifts in the aging mouse gut. Microbiome 2, 50 (2014).
Boehme, M. et al. Microbiota from young mice counteracts selective age-associated behavioral deficits. Nat. Aging 1, 666–676 (2021).
Mossad, O. et al. Microbiota-dependent increase in δ-valerobetaine alters neuronal function and is responsible for age-related cognitive decline. Nat. Aging 1, 1127–1136 (2021).
Uchimura, Y. et al. Antibodies set boundaries limiting microbial metabolite penetration and the resultant mammalian host response. Immunity 49, 545–559.e5 (2018).
Tremblay, M.-È., Zettel, M. L., Ison, J. R., Allen, P. D. & Majewska, A. K. Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia 60, 541–558 (2012).
Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232–236 (2011).
Streit, W. J. Microglial senescence: does the brain’s immune system have an expiration date? Trends Neurosci. 29, 506–510 (2006).
Sun, J., Druhan, L. J. & Zweier, J. L. Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production. Arch. Biochem. Biophys. 494, 130–137 (2010).
Zhao, K., Huang, Z., Lu, H., Zhou, J. & Wei, T. Induction of inducible nitric oxide synthase increases the production of reactive oxygen species in RAW264.7 macrophages. Biosci. Rep. 30, 233–241 (2010).
Stefanatos, R. & Sanz, A. The role of mitochondrial ROS in the aging brain. FEBS Lett. 592, 743–758 (2018).
Gomes, A. P. et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624–1638 (2013).
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
Shi, H. et al. A fiber-deprived diet causes cognitive impairment and hippocampal microglia-mediated synaptic loss through the gut microbiota and metabolites. Microbiome 9, 223 (2021).
Thangthaeng, N., Sumien, N. & Forster, M. J. Dissociation of functional status from accrual of CML and RAGE in the aged mouse brain. Exp. Gerontol. 43, 1077–1085 (2008).
Ke, Y. et al. Gut flora-dependent metabolite trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress. Free Radic. Biol. Med. 116, 88–100 (2018).
Colombo, A. V. et al. Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition. eLife 10, e59826 (2021).
Erny, D. et al. Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab. 33, 2260–2276.e7 (2021).
Mezö, C. et al. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer’s disease. Acta Neuropathol. Commun. 8, 119 (2020).
Tessier, F. J. et al. Quantitative assessment of organ distribution of dietary protein-bound 13C-labeled Nɛ-carboxymethyllysine after a chronic oral exposure in mice. Mol. Nutr. Food Res. 60, 2446–2456 (2016).
Mariat, D. et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9, 123 (2009).
Hayes, C. L. et al. Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis. Sci. Rep. 8, 14184 (2018).
Thevaranjan, N. et al. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe 21, 455–466.e4 (2017).
Raghu, G., Jakhotia, S., Yadagiri Reddy, P., Kumar, P. A. & Bhanuprakash Reddy, G. Ellagic acid inhibits non-enzymatic glycation and prevents proteinuria in diabetic rats. Food Funct. 7, 1574–1583 (2016).
Kühn, F. et al. Intestinal alkaline phosphatase targets the gut barrier to prevent aging. JCI Insight 5, e134049 (2020).
Singh, S. B., Carroll-Portillo, A., Coffman, C., Ritz, N. L. & Lin, H. C. Intestinal alkaline phosphatase exerts anti-inflammatory effects against lipopolysaccharide by inducing autophagy. Sci. Rep. 10, 3107 (2020).
Grabert, K. et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 19, 504–516 (2016).
Hammond, T. R. et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253–271.e6 (2019).
Koellhoffer, E. C., McCullough, L. D. & Ritzel, R. M. Old maids: aging and its impact on microglia function. Int. J. Mol. Sci. 18, 769 (2017).
Kettenmann, H., Kirchhoff, F. & Verkhratsky, A. Microglia: new roles for the synaptic stripper. Neuron 77, 10–18 (2013).
Guo, C., Sun, L., Chen, X. & Zhang, D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen. Res. 8, 2003–2014 (2013).
Enciu, A.-M., Gherghiceanu, M. & Popescu, B. O. Triggers and effectors of oxidative stress at blood–brain barrier level: relevance for brain ageing and neurodegeneration. Oxid. Med. Cell. Longev. 2013, 297512 (2013).
Luceri, C. et al. Aging related changes in circulating reactive oxygen species (ROS) and protein carbonyls are indicative of liver oxidative injury. Toxicol. Rep. 5, 141–145 (2018).
Cramer, T. et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645–657 (2003).
Wenzel, T. J., Gates, E. J., Ranger, A. L. & Klegeris, A. Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells. Mol. Cell. Neurosci. 105, 103493 (2020).
Basta, G. et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105, 816–822 (2002).
Dyer, D. G. et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91, 2463–2469 (1993).
Gironès, X. et al. Nϵ-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer’s disease. Free Radic. Biol. Med. 36, 1241–1247 (2004).
Wong, A. et al. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer’s disease. Brain Res. 920, 32–40 (2001).
Xue, J. et al. Advanced glycation end product recognition by the receptor for AGEs. Structure 19, 722–732 (2011).
Spychala, M. S. et al. Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome. Ann. Neurol. 84, 23–36 (2018).
Vaiserman, A. et al. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol. 20, 221 (2020).
Hu, S. et al. Anti-inflammation effects of fucosylated chondroitin sulphate from Acaudina molpadioides by altering gut microbiota in obese mice. Food Funct. 10, 1736–1746 (2019).
Long, T. et al. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites. Nat. Genet. 49, 568–578 (2017).
Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537–W544 (2018).
Jordão, M. J. C. et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363, eaat7554 (2019).
Yilmaz, B. et al. Microbial network disturbances in relapsing refractory Crohn’s disease. Nat. Med. 25, 323–336 (2019).
Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335–336 (2010).
McMurdie, P. J. & Holmes, S. Phyloseq: a Bioconductor package for handling and analysis of high-throughput phylogenetic sequence data. Pac. Symp. Biocomput. 235–246 (2012).
Callahan, B. J., Sankaran, K., Fukuyama, J. A., McMurdie, P. J. & Holmes, S. P. Bioconductor workflow for microbiome data analysis: from raw reads to community analyses. F1000Res. 5, 1492 (2016).
Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M. & Milgram, E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal. Chem. 81, 6656–6667 (2009).
Harris, D. C. Quantitative Chemical Analysis 6th edn (W H Freeman and Co., 2003).
Mossad, O., Yilmaz, B. & Blank, T. Dataset for gut microbiota drives age-related oxidative stress and mitochondrial damage in microglia via the metabolite N(6)-carboxymethyllysine. https://doi.org/10.6084/m9.figshare.15179775.v1 (2022).
Acknowledgements
We thank E. Barleon and K. Seidel for helping with IHC and electron microscopy. J. Bodinek-Wersing (Core Facility, University of Freiburg) was responsible for cell sorting. We thank the Metabolomics Core Facility (University of Freiburg) and in particular D. Pan for technical assistance. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, National Institute for Health Research-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy’s and St. Thomas’ NHS Foundation Trust in partnership with King’s College London. We thank C. Moehle and T. Stempfl (University of Regensburg) for technical assistance with the RNA-seq experiments. We thank M. Havermans for providing the BMDMs. We thank A. Dumas for proofreading the manuscript. This study was funded by the Deutsche Forschungsgemeinschaft (DFG) SFB/TRR 167 to T.B., T.L., D.E., R.B. and M.P. D.E. was further supported by the Berta Ottenstein Program for Advanced Clinician Scientists. M.P. was further supported by the Sobek Foundation, Ernst-Jung Foundation, DFG (SFB 992, SFB1160, Reinhart Koselleck Grant, Gottfried Wilhelm Leibniz-Prize), Alzheimer Forschung Initiative and the Ministry of Science, Research and Arts, Baden-Württemberg (‘Neuroinflammation’ specialization). This study was supported by the DFG under Germany’s Excellence Strategy (CIBSS, EXC-2189; project ID 390939984).
Author information
Authors and Affiliations
Contributions
O.M. performed most of the experiments, helped develop the overall concept and wrote the manuscript. B.Y. and S.C.G.V. analyzed the microbiome profile within the fecal samples. M.G.D.A. bred and prepared the mice of the different age groups. B.B. and R.B. performed and designed the analyses of the RNA-seq data. E.N. and J.M.B. performed the targeted metabolomics. L.S.N., M.M., F.J.M.M., C.M. and N.D. provided help with the experiments and experimental design. T.L., A.S., A.J.M., D.E. and M.P. contributed to critical analysis of the data, developed the concepts and provided the reagents. T.B. developed the overall concept of the project, supervised the experiments and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Neuroscience thanks John Cryan, Sarkis Mazmanian, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Microglial transcriptional profile from GF and SPF mice of both sexes.
(a) Heatmap of genes (normalized gene counts) specific to different types of immune cells in order to show purity of sorted cells. (b) Heatmap showing sample−to-sample Ward clustering. (c) Heatmap of all genes in the modules eigengenes. Each row is a biological replicate (d) Heatmap of genes in metabolism-associated module eigengene ME10. Z-scores were calculated from normalized counts. Each row is a gene, and each column is a biological replicate; microglia isolated from young-adult and aged SPF (n = 6, 16) and GF (n = 6, 8) mice.
Extended Data Fig. 2 Gating strategy for flow cytometry and purity of MACS separation.
(a) Cell sorting strategy for RT-qPCR and RNA-seq. (1) Myeloid cells were gated by size and granularity then (2 and 3) only single cells were included. (4) Live and Lineage- cells were gated negative for Fixable Viability Dye eFluor® 780 and CD3, CD19, CD45R, Ly6C, and Ly6G to exclude T cells, B cells, monocytes and granulocytes, respectively. Microglia were gated on CD45Int and CD11b+. (b) Purity of cells used for for cellular ATP assay. Microglial cells were enriched using the CD11b MACS cell separation system (Miltenyi Biotec, USA). (b, left panel) Each dot represents one mouse. Data are presented as mean values + /- SEM.
Extended Data Fig. 3 Microbiota drives age-related differences in microglial morphology but not in cell density.
(a) Immunohistological detection of Iba-1+ microglia in the cortex of young-adult and aged SPF and GF mice. Scale bar, 20 μm. (b) Diagram summarizing microglia densities in the cortex. SPF (n = 9, 8) and GF (n = 9, 8). (c) Representative three-dimensional reconstruction of cortical microglia of all groups. Scale bar, 10 µm. (d-h) Imaris-based semi-automatic quantification of cell morphology. (d) Total branch length (µm), (e) total branch area (µm2), (f) number of branch points, (g) cell body volume (µm3) and (h) cell body sphericity. Each symbol represents an average of at least four cells measured per mouse. Data represent two independent experiments including young-adult and aged mice. SPF (n = 8, 8) and GF (n = 8, 8). Statistical analysis (b-h) two-way ANOVA followed by Tukey’s post-hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ns = not significant). Data are presented as mean values + SEM. Exact p-values are reported in the source data.
Extended Data Fig. 4 Age-related mitochondrial physiology in microglia of male and female SPF and GF mice.
(a) Representative electron micrographs of abnormal vs healthy mitochondria in cortical microglia. Scale bar, 600 nm. (b) Quantification of mitochondrial area per microglia. (c) Number of mitochondria per microglia. (b and c) Data were generated from aged SPF and GF mice (n = 8). (d) Hif1a mRNA expression in microglia based on RNA-seq analysis (normalized gene counts). (e) Hif1a mRNA expression by RT-qPCR in microglia of young-adult and aged SPF (n = 8, 8) and GF (n = 7, 10) mice. (f) Mitochondrial mass (MitoTracker Green MFI). (g) Mitochondrial membrane potential (Δψm) (TMRM dye MFI). (h) Quantification of cellular ATP relative to young-adult SPF males. Data were generated from young-adult and aged mice. (f and g) SPF (n = 17, 14) and GF (n = 9, 13). (h) SPF (n = 23, 17) and GF (n = 14, 11). (b-h) Data are presented as mean values + SEM. Statistical analysis (b and c) Mann−Whitney U test (two-sided), and (e-h) two-way ANOVA followed by Tukey’s post-hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ns = not significant). Exact p-values are reported in the source data.
Extended Data Fig. 5 CML modulates macrophage metabolism.
(a, b) Pathway enrichment analysis for significantly abundant metabolites in serum and brain of aged mice (plotted are the top 15 enriched pathways). Color scale (blue to red), ratio between the number of significant metabolites to the total number of metabolites detected in each pathway. Dot size reflects number of significant metabolites in each pathway. Pathway enrichment analysis was performed automatically using the Metabolon’s client portal. (c) Percentage of healthy vs abnormal mitochondria from total mitochondrial number in cortical microglia of young-adult mice treated with vehicle or CML i.p. (n = 5). (d and e) Bone marrow derived macrophages (BMDMs) were cultured in serum-free medium 6 h before the experiment. Cells were incubated with increasing concentrations of CML for 48 h, before harvesting for measurements. Each dot is a biological replicate (n = 3). (d) Quantification of relative MFI of CellROX probe signals. (e) Mitochondrial activity depicted as mitochondrial membrane potential (Δψm) (TMRM dye MFI) normalized to mitochondrial mass (MitoTracker Green MFI). (f) PCA on transcriptome (normalized gene counts) of microglia isolated from young-adult mice treated with vehicle or CML i.p.. (c-f) Data are presented as mean values + SEM. Each dot represents one mouse. Statistical analysis (c) two-way ANOVA followed by Sidak’s multiple comparisons test, (d and e) one-way ANOVA followed by Dunnett’s post-hoc test (***p < 0.001, ns = not significant). Exact p-values are reported in the source data.
Extended Data Fig. 6 Age-dependent shift in gut microbiota composition.
(a) PCA plot (beta-diversity) and (b) Shannon and Simpson alpha-diversity indices of gut microbiota. Non-parametric Mann-Whitney U-tests (two-sided) to compare alpha diversity between samples and Adonis from vegan package to assess the effects of groups for beta diversity. (c) Relative abundance of gut microbiota composition profiles at the phylum level in male mice at different ages (each color represents one bacterial phylum). (d) The average Firmicutes/Bacteroidetes ratio (F/R) in the cecal samples. (e) Relative abundance of the family Lachnospiraceae. (a-f) Data from young-adult and aged male mice, housed under SPF conditions (n = 5, 10). Each dot represents data from one animal. (d and e) Data are presented as mean values + SEM. (b and f) Box plots; centre = median, upper and lower “hinges” correspond to the first and third quartiles (the 25th and 75th percentiles), upper whisker extends from the hinge to the highest value that is within 1.5 * IQR of the hinge, and lower whisker extends from the hinge to the lowest value within 1.5 * IQR of the hinge, where IQR is the inter-quartile range, or distance between the first and third quartiles. (d and e) Statistics with Mann-Whitney U test (two-sided) (f) Relative abundance of differentially abundant genera in aging. Taxonomic differences at phylum and genus levels between tested groups were identified using the “multivariate analysis by linear models” (MaAsLin) R package.
Extended Data Fig. 7 Age-related microglial CML accumulation is gut-mediated.
(a) Targeted metabolomics (LC/MS) on CML translocated into the circulation 4 h post oral gavage in young-adult and aged mice housed under SPF or GF (n = 5). Light purple; before gavage, green; 4 h post gavage. Each dot represents an individual measurement for one mouse. (b-e) Data from young-adult and aged SPF mice injected with vehicle or CML (i.p. or o.g.) (n = 4 each). Each dot represents one mouse. (b) Percentage of CML+ Iba-1+ cells quantified in the cortex. (c) Immunofluorescent labelling of CML (Red), Iba-1 (green) and DAPI (blue) in mouse cortex. Scale bars, 50 µm (overview) and 10 µm (inset). (d) Quantification of relative CellROX probe signal by determining MFI and (e) quantification of relative cellular ATP. (a, b, d and e) Each dot represents one mouse. Data are presented as mean values + SEM. Statistical analysis (b, d and e) two-way ANOVA followed by Tukey’s post-hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ns = not significant). Exact p-values are reported in the source data.
Supplementary information
Supplementary Table
Supplementary Tables 1–8
Source data
Source Data Fig. 1
Statistical Source Data.
Source Data Fig. 2
Statistical Source Data.
Source Data Fig. 3
Statistical Source Data.
Source Data Fig. 4
Statistical Source Data.
Source Data Extended Data Fig. 1
Statistical Source Data.
Source Data Extended Data Fig. 2
Statistical Source Data.
Source Data Extended Data Fig. 4
Statistical Source Data.
Source Data Extended Data Fig. 5
Statistical Source Data.
Source Data Extended Data Fig. 7
Statistical Source Data.
Rights and permissions
About this article
Cite this article
Mossad, O., Batut, B., Yilmaz, B. et al. Gut microbiota drives age-related oxidative stress and mitochondrial damage in microglia via the metabolite N6-carboxymethyllysine. Nat Neurosci 25, 295–305 (2022). https://doi.org/10.1038/s41593-022-01027-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41593-022-01027-3
This article is cited by
-
Dysregulation of neuroprotective lipoxin pathway in astrocytes in response to cytokines and ocular hypertension
Acta Neuropathologica Communications (2024)
-
Gut microbiota contributes to bisphenol A-induced maternal intestinal and placental apoptosis, oxidative stress, and fetal growth restriction in pregnant ewe model by regulating gut-placental axis
Microbiome (2024)
-
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Translational Neurodegeneration (2024)
-
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Molecular Neurodegeneration (2024)
-
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Signal Transduction and Targeted Therapy (2024)